Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.5 Million Underwritten Public Offering of American Depositary Shares of Medigus Ltd.
Press Release – New York, NY – March 2, 2021– Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the underwritten public offering of 3,258,438 American Depositary Shares (the “ADSs”) of Medigus Ltd. (NASDAQ: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies. The ADSs were sold to the public at a price of $2.60 per ADS for gross proceeds of approximately $8.5 million.
This offering was made pursuant to an effective registration statement on Form F-3 (No 333-238162) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on May 15, 2020.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Barrett DiPaolo and associate Terra Melson.
- Sichenzia Ross Ference LLP Represents Madison Global Partners, LLC in $8.2 Million Simultaneous Registered Direct Offering and Private Placement of Securities of authID Inc. - June 2, 2023
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp.in $1.7 Million At-The-Market Offering Facility with SciSparc Ltd. - May 24, 2023
- Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $5.0 Million Private Placement Priced At-the-Market - May 16, 2023